Universal-Beteiligungs- und Servicegesellschaft’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
Other funds holding ADMA
N
RIM
LCIP
Universal-Beteiligungs- und Servicegesellschaft's ADMA Position: Q2 2026 in Review
Universal-Beteiligungs- und Servicegesellschaft reduced its ADMA Biologics (ADMA) stake by 58% in Q2 2026, selling an estimated $441K and leaving 34,929 shares worth $292K. The position accounts for ﹤0.01% of the portfolio, ranked #1939.
Universal-Beteiligungs- und Servicegesellschaft first reported a position in ADMA in Q1 2025 and has held it in 6 quarters since. The position peaked at $5.06M in Q1 2025. 212 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.
- Universal-Beteiligungs- und Servicegesellschaft held 34,929 shares of ADMA Biologics worth $292K as of Q2 2026.
- Universal-Beteiligungs- und Servicegesellschaft sold 48,427 ADMA Biologics shares in Q2 2026, an estimated $441K.
- ADMA Biologics made up ﹤0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #1939 holding.
- Universal-Beteiligungs- und Servicegesellschaft first reported a position in ADMA Biologics in Q1 2025 and has held it in 6 quarters since.
- Universal-Beteiligungs- und Servicegesellschaft's ADMA Biologics position peaked at $5.06M in Q1 2025.
- 212 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.
Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.